Developing MCMs to Treat Acute and Chronic Effects of Ocular Chemical Toxicity
February 25 - February 26
A U.S. Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity will be held Feb 25-26, 2020 at the NIAID Conference Center in Rockville, Md.
This meeting, sponsored by the NIH Chemical Countermeasures Research Program (CCRP) and organized in collaboration with the National Eye Institute (HHS/NIH/NEI) and U.S. Army Medical Research Institute for Chemical Defense (DoD/USAMRICD), will bring together subject matter experts from the civilian and military research communities to discuss the current state of the field, including potential therapeutic approaches and available models.
Development of MCMs that mitigate acute and chronic corneal manifestations in response to ocular toxicants relies on the development of well-characterized experimental models with defined pathophysiology that allow for effective bridging to humans. Such models are also essential to demonstrate therapeutic efficacy.
Attendees of the workshop will contribute to our understanding of pathologies and models available for studying toxic ocular injuries and their utility in the research and development of therapeutics. Most importantly, the workshop will address current knowledge gaps to identify possible refinements or new directions to advance MCM development.
Highlighted session topics include:
- Acute and Chronic Wound Healing Responses to Corneal Toxicity
- Mechanistic Basis of Corneal Pathophysiologies
- Therapeutically Accessible Models of Corneal Toxic Injury
- Therapeutic Approaches to Mitigate Corneal Pathophysiologies
- Current Research & Development Perspectives and Resources for Researchers
- Meeting Wrap Up
Please visit the NIAID event website for more information. Register by January 31, 2020.
Edited by S. Lizotte